According to several studies, the rate of cancer cell proliferation and tumor aggressiveness were linked with the overexpression of FXR in different cancers of breast, esophageal, lung, pancreas, and thyroid [43, 319–321]. The gene discussed is NR1H4; the disease is cancer.